ZHENGYE BIOTECHNOLOGY-A
ZYBTNASDAQ🏆 #4944 by market capUS Equity
$1.47▲ $0.04 (+2.80%)
Market closed · at closeTrack ZYBT
Get earnings, price moves & breaking news on Telegram
24h▲ 2.8%
7d▼ 1.0%
14d▼ 8.7%
30d▲ 7.3%
ytd▲ 27.8%
1y▼ 41.9%
🏦Market Cap
$44M
Small Cap
📈Revenue Growth (YoY)
-4.2%
Declining
📊Gross Margin
24.2%
Moderate
💵FCF Margin
8.6%
Moderate
⚖️P/S Ratio
1.6x
Cheap
Otter Score
—
Insufficient data
Trading Snapshot
- Day Range
- $1.47 – $1.47
- 52-Week Range
- —
- Volume (shares)
- 100
- Avg Volume (shares)
- —
- Shares Outstanding
- 29.7M
- Next Earnings
- —
Fundamentals Snapshot
- Annual Revenue
- $116M
- Last Q Revenue
- $53M
- P/E Ratio
- —
- P/S Ratio
- 1.6x
- EPS (TTM)
- —
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +3.8%
ZHENGYE BIOTECHNOLOGY-A
ZYBTFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$116M▼ −37.6% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
20.5%▼ −58.1% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$68M▼ −515.2% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$703K▼ −94.7% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
47.4M▲ +3.8% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
−$25M▲ +$43M YoY
StockOtter · stockotter.spaceAbout ZHENGYE BIOTECHNOLOGY-A
Zhengye Biotechnology Holding Limited specializes in the creation, manufacturing, and commercialization of animal health immunizations. The company primarily supplies the Chinese agricultural sector with vaccines tailored for a broad spectrum of farm animals, including swine, bovines, goats, ovines, and poultry. Additionally, its product range encompasses inoculations for canines. Beyond its domestic reach, the firm also distributes its offerings to international markets, notably exporting to Vietnam, Pakistan, and Egypt. Established in 2004, this enterprise bases its principal operations in Jilin, China, and operates as a subsidiary entity of Securingium Holding Limited.
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
💧Dilution★★★★★
Overall Score
Insufficient data
—/100
Analyst data unavailable.
Latest News & Updates
News unavailable.